SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041314
Filing Date
2023-08-10
Accepted
2023-08-10 16:09:22
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-20230630.htm   iXBRL 10-Q 3508803
2 EX-10.1 spro-ex10_1.htm EX-10.1 127389
3 EX-10.2 spro-ex10_2.htm EX-10.2 144958
4 EX-10.3 spro-ex10_3.htm EX-10.3 196346
5 EX-10.4 spro-ex10_4.htm EX-10.4 93699
6 EX-31.1 spro-ex31_1.htm EX-31.1 12755
7 EX-31.2 spro-ex31_2.htm EX-31.2 12807
8 EX-32 spro-ex32.htm EX-32 11586
  Complete submission text file 0000950170-23-041314.txt   11108611

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT spro-20230630.xsd EX-101.SCH 70833
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT spro-20230630_pre.xml EX-101.PRE 388613
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT spro-20230630_cal.xml EX-101.CAL 41809
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT spro-20230630_def.xml EX-101.DEF 235074
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT spro-20230630_lab.xml EX-101.LAB 504685
61 EXTRACTED XBRL INSTANCE DOCUMENT spro-20230630_htm.xml XML 1695975
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 231159394
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences